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ATF3Previous global transcriptome and interactome analyses of copper-treated HepG2 cells identiﬁed hepatocyte
nuclear factor 4α (HNF4α) as a potential master regulator of copper-responsive transcription. Copper
exposure caused a decrease in the expression of HNF4α at both mRNA and protein levels, which was
accompanied by a decrease in the level of HNF4α binding to its consensus DNA binding sequence. qRT-PCR
and RNAi studies demonstrated that changes in HNF4α expression ultimately affected the expressions of its
down-stream target genes. Analysis of upstream regulators of HNF4α expression, including p53 and ATF3,
showed that copper caused an increase in the steady-state levels of these proteins. These results support a
model for copper-responsive transcription in which the metal affects ATF3 expression and stabilizes p53
resulting in the down-regulation of HNF4α expression. In addition, copper may directly affect p53 protein
levels. The suppression of HNF4α activity may contribute to the molecular mechanisms underlying the
physiological and toxicological consequences of copper toxicity in hepatic-derived cells.; ATF3, activating transcription
A interference; siRNA, small
; SREBP-2, sterol regulatory-
+1 919 541 5737.
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Copper is an essential transition metal that has important
physiological roles [1,2]. At supra-physiological concentrations,
however, it can damage intracellular components through the
generation of reactive oxygen species, which react with lipids,
proteins, and DNA. Copper also directly binds to protein sulfhydryl
and amino groups to produce structural and functional abnormalities
[3–7]. To defend against copper toxicity, cells activate the transcrip-
tion of a variety of genes whose products detoxify the metal and its
reactive by-products, and repair intracellular damage [6,8,9]. Tran-
scriptome analysis of HepG2 cells exposed to various concentrations
of copper for 4, 8, 12, and 24 h reveals that at low levels of exposure,
copper modulates the expression of genes associated with physio-
logical/adaptive responses. Similarly, high levels of exposure affect
genes involved in the response to stress [10].
During the analysis of the HepG2 copper transcriptome, using
Ingenuity Pathways Analysis and Cytoscape, hepatocyte nuclear factor
4α (HNF4α) modules were identiﬁed as signiﬁcant subnetworks
(Fig. 1). This suggests that HNF4α may be an important regulator
affecting the transcription of copper-responsive genes and transmit-
ting copper-induced stress signals to downstream target genes.Hepatocyte nuclear factors (HNFs) are a family of transcription
factors that regulate liver-speciﬁc gene expression and hepatocyte
differentiation [11–14]. SomeHNFs (HNF1α, HNF4α, HNF6) form core
transcriptional regulatory circuitry with other transcription factors
including CREB1, USF1, and FOXA2 [15]. HNF4α expression is
essential for early embryonic development, hepatocyte differentia-
tion, and liver-speciﬁc gene expression [13,14,16]. Chromatin immu-
noprecipitation and promoter microarray analysis indicate that
HNF4α controls the expression of 1829 genes in human hepatocytes
[15]. In addition, in the human Biomolecular Interaction Network
Database, the HNF4α subnetwork consists of 2313 genes and 2606
interactions [17]. Potential HNF4α target genes have been identiﬁed
and include those encoding apolipoproteins, blood coagulation
factors, and enzymes involved in lipid, amino acid, and glucose
metabolism [18–20]. Many of these target genes were also identiﬁed
in the copper transcriptome [10]. Protein binding microarrays
identiﬁed more than 1400 new HNF4α binding sequences and, in
combination with Support Vector Machine models, N240 new HNF4α
human target genes.
Based on copper transcriptome analyses, the molecular mecha-
nism of copper-induced down-regulation in HNF4α expression in
HepG2 cells was investigated. A detailed examination of the effects of
copper on HNF4α mRNA and protein levels revealed that copper
caused decreases in the steady-state levels of HNF4α expression and
activity. It has been reported that p53 down-regulates HNF4α
expression [21]. The mechanism by which copper-induced stress
and p53 and ATF3 activity affects HNF4α expression was also
explored. The results support a model in which HNF4α is a master
regulator of copper-responsive transcription. In addition, HNF4α
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target genes. The present study is the ﬁrst to demonstrate that HNF4α
is associated with the molecular mechanism of copper toxicity in
human hepatocytes.
2. Materials and methods
2.1. Cell culture and RNA interference
HepG2 cells (human hepatocellular carcinoma cell line, ATCC#HB-
8065) were grown in minimal essential medium, supplemented with
10% heat-inactivated fetal bovine serum, 100 μM nonessential amino
acids, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 μg/ml
streptomycin (Invitrogen/Life Technologies, Carlsbad, CA). Cells were
maintained in a humidiﬁed incubator at 37 °C under 5% CO2.
For RNA interference (RNAi), HepG2 cells were reverse transfected
with single duplex siRNA of ATF3, HNF4α (Dharmacon, Lafayette, CO),
p53 (Qiagen, Inc., Valencia, CA), or non-homologous siRNA at a ﬁnal
concentration of 50 nMwith Lipofectamine 2000. Brieﬂy, transfection
complexes of siRNA and Lipofectamine 2000 were prepared following
the manufacturer's instructions (Invitrogen) and dispensed into 6-
well plates. HepG2 cells were then added to wells that contained
transfection complexes. Following 44 h of incubation, cells were
treated with 400 μM copper, as copper sulfate (Sigma-Aldrich, St
Louis, MO) for 4 h.
2.2. RNA isolation and quantitative real-time PCR
For quantitative real-time PCR (qRT-PCR), total RNA from three or
more independent transfections was isolated from untreated and
treated cells using RNeasy mini kits following the manufacturer's
instructions (Qiagen). cDNAs were then generated for two-step qRT-
PCR using the SuperScript® First-Strand Synthesis System for RT-PCR
according to the manufacturer's instructions (Invitrogen). cDNAs
were subsequently used in qRT-PCR using Power SYBR Green RT-PCR
kits according to themanufacturer's instructions (Applied Biosystems,
Foster City, CA). Quantitative PCR was performed using an ABI 7900
HT Fast Real-Time System (Applied Biosystems). The fold changes in
mRNA levels were calculated using the ΔΔCt method with β-actin as
reference mRNA [22,23]. PCR primers for HNF4α, TXNRD1 (thior-
edoxin reductase 1), G6PC (glucose-6-phosphatase, catalytic subunit),
ATF3 (activating transcription factor 3), LIPA (lipase A), APOC1
(apolipoprotein C1), APOM (apolipoprotein M), and p53 were pur-
chased as QuantiTect® Primer Assays (Qiagen). Primers for UCHL1
(ubiquitin carboxyl-terminal esterase L1) and β-actin (Table 1) were
designed using Primer3 [24] and purchased from Integrated DNA
Technologies (Coralville, IA).
2.3. Western immunoblot analysis
Whole cell lysates were prepared for Western immunoblot
analysis by adding SDS sample buffer (62.5 mM Tris–HCl (pH 6.8),
2% (wt./vol.) SDS, 10% (vol./vol.) glycerol and 50 mM DTT) to PBS-
washed cells and sonicating the mixture for 10–15 sec. The lysate was
then centrifuged for 3 min at 14,000×g at 4 °C, and the supernatant
was collected. Nuclear extracts were prepared using Active Motif
(Carlsbad, CA) nuclear extract kits following the manufacturer's
instructions. Protein concentrations were determined using the
Bradford dye-binding assay (Bio-Rad Laboratories, Hercules, CA).
Proteins were resolved on 4%–12% Bis–Tris gels (NuPAGE Novex,Fig. 1. HNF4α networks. (A) Ingenuity pathway analysis network of differentially
expressed genes fromHepG2 cells exposed to 600 μMcopper for 24 h. Red indicates up-
regulated and green indicates down-regulated genes. Cytoscape HNF4α modules of
genes with N1.5-fold increase (B) or N2-fold decrease (C) in expression following an 8 h
exposure to 400 μM copper. Data used in these analyses are from Song et al. [10].
Table 2
Effect of copper and decreased HNF4α expression on gene expression.
Gene Expression level (%)a HNF4α
leveld
Control siRNA+
400 μM copper
HNF4α siRNA HNF4α siRNA+
400 μM copper
LIPA 66±14b 28±5c 12±3b,c 22±2
APOM 76±8b 52±8c 36±8b,c
APOC1 67±9b 60±11c 43±10b,c
G6PC 23±3b 33±8c 7±2b,c 18±3
UCHL1 324±51b 155±57 580±135b 33±8
TXNRD1 296±30b 54±6c 171±23b,c 34±7
a Values are expressed as percent±SE relative to mRNA levels measured in cells
transfected with nonhomologous control siRNA.
b Signiﬁcantly different from sample without copper (pb0.05).
c Signiﬁcantly different from non-homologous control (pb0.05).
d These values present the mean percent of HNF4αmRNA remaining following RNAi
treatment for the indicated target gene(s).
Table 1
Sequences of primers used for qRT-PCR.
Gene Sequence
UCHL1 Forward 5′-ACCGAGCGTGAGCAAGGAGAAGTC-3′
Reverse 5′-GAAGGGAAGAGGGGAAATCAGC-3′
β-actin Forward 5′-GATATCGCTGCGCTGGTCGTC-3′
Reverse 5′-ACGCAGCTCATTGTAGAAGGTGTGG-3′
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ting was performed using polyclonal antibodies against HNF4α, p53,
β-actin, tubulin (Cell Signaling Technology, Danvers, MA), ATF3
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA), and histone 3
(Millipore, Billerica, MA). HPR-conjugated secondary antibodies were
obtained from Cell Signaling Technology. Antigen–antibody com-
plexes were visualized using enhanced chemiluminescence (GE
Healthcare, Piscataway, NJ) following exposure to X-ray ﬁlm. Target
protein levels were measured by densitometry and quantiﬁed using
Image J software [25]. Data were expressed as fold change of treated
samples compared to untreated cells, normalized to the level of
β-actin, tubulin, or histone 3. Each experiment was repeated at
least three times.
2.4. HNF4α binding assay
HepG2 cells were grown to 70%–80% conﬂuence and then treated
with 100, 200, 400, or 600 μMcopper for 0.5, 1, 2, 4, or 8 h, and nuclear
extracts were prepared. Protein binding to the HNF4α consensus
binding motif (5′-TGGACTTAG-3′) was measured using TransAM HNF
family transcription factor assay kits according to the manufacturer's
instructions (Active Motif). Brieﬂy, 8 μg of nuclear protein was added
to wells containing a mixture of immobilized oligonucleotides that
contained HNF-1, HNF-3, and HNF-4 consensus binding sequences
and incubated at room temperature. Wells were washed and then
anti-HNF4α antibody was added. Following a 1-h incubation and
washing, HRP-conjugated secondary antibodywas added and allowed
to incubate for 1 h at room temperature. Wells were washed, and the
developing solution was added. Reactions were terminated and then
the absorbance at 450 nm measured using a FLUOstar OPTIMA plate
reader (BMG Labtech, Durham, NC). To conﬁrm the speciﬁcity of
HNF4α binding, competition studies were performed using oligonu-
cleotides with wild-type (Active Motif) or mutant (Santa Cruz
Biotechnologies, Inc) HNF4α consensus sequences, according to the
manufacturer's instructions.
2.5. Statistical analysis
All statistical analyses were performed using StatView software
(SAS Institute Inc., Cary, NC). The results are presented as themeans±
standard error. The signiﬁcance of mean differences was detected by
analysis of variance (ANOVA) followed by Fisher's protected least
squares differences post hoc test for individual comparisons.
3. Results
3.1. Effect of HNF4α and copper on HNF4α-regulated gene expression
The effect of decreased HNF4α expression on steady-state mRNA
levels of several cognate target genes was determined using qRT-PCR.
Speciﬁc HNF4α- regulated genes were selected based on the previous
analysis of the HepG2 copper transcriptome [10]. Target genes based
on pathway and network analysis included UCHL1, G6PC, and
TXNRD1; and pathway mapping and literature mining included
LIPA, APOC1, and APOM [18].
Transcriptome analysis showed that LIPA, APOC1, and APOMwere
signiﬁcantly down-regulated following copper treatment [10]. Con-sistent with previous microarray data, mRNA levels of LIPA, APOC1,
and APOM were 66% (p=0.0048), 67 % (p=0.0093), and 76%
(p=0.0085) of that observed in nontreated cells, respectively,
following a 4-h treatment with 400 μM copper (Table 2). In addition,
knocking down the expression of HNF4α using RNAi resulted in
signiﬁcant decreases in steady-state mRNA levels of LIPA, APOC1, and
APOM; 28% (pb0.0001), 60% (p=0.0018), and 52% (pb0.0001)
relative to cells transfected with a nonhomologous control siRNA,
respectively (Table 2). A combination of HNF4α siRNA and copper
further down-regulated LIPA, APOC1, and APOM mRNA levels to 12%
(p=0.0048), 43% (p=0.0093), and 36% (p=0.0085) of that observed
in control cells, respectively. These levels were signiﬁcantly lower
than those observed in cells exposed to copper alone (Table 2).
The promoter of G6PC, a key enzyme in glucose homeostasis,
contains an HNF4α consensus binding sequence. It has been
suggested that polyunsaturated fatty acyl CoA suppresses G6PC
transcription by modulating HNF4α DNA binding activity [26].
Decreased HNF4α expression caused a signiﬁcant reduction in
steady-state G6PC mRNA levels, 33% relative to cells transfected
with nonhomologous control siRNA (pb0.0001). Exposure to copper
decreased G6PC expression to 23% relative to control (pb0.0001) and
the combination of HNF4α siRNA and copper signiﬁcantly reduced
G6PC mRNA levels to 7% of that observed in control cells (p=0.0003)
(Table 2).
HNF4α was reported to be a negative regulator of UCHL1
transcription in human hepatoma HuH7 cells [27]. Thus, decreased
expression of HNF4α in HepG2 cells should produce an increase in the
steady-state mRNA level of UCHL1. UCHL1 expression showed a
nonsigniﬁcant (p=0.0586) 155% increase, relative to control cells
when HNF4α expression was reduced (Table 2). However, HepG2
copper transcriptome analysis showed that copper signiﬁcantly
upregulated UCHL1 expression more than 1.5-fold in 8 out of 16
treatment conditions [10]. Exposure to 400 μM copper for 4 h caused a
statistically signiﬁcant (p=0.0005) 324% increase in UCHL1 mRNA
levels. A combination of reduced HNF4α expression and copper
treatment caused a signiﬁcant 580% increase in UCHL1 expression.
These results conﬁrmed that UCHL1 is a copper-responsive gene;
however, the effect of HNF4α on UCHL1 expression was not clear.
In cells exposed to 400 μM copper for 4 h, TXNRD1 was identiﬁed
as a signiﬁcant subnetwork of the HNF4α module [10] (Fig. 1B).
Inhibition of HNF4α expression caused a signiﬁcant (p=0.0002)
decrease in TXNRD1 expression, 54% relative to control cells (Table 2).
Treatment with copper alone caused a 296% increase in TXNRD1
expression (pb0.0001) while both decreased HNF4α expression and
copper treatment produced a 171% increase in TXNRD1 expression
(p=0.0506). These results suggest that copper affects TXNRD1
expression by a mechanism that may be independent of HNF4α.
105M.O. Song, J.H. Freedman / Biochimica et Biophysica Acta 1813 (2011) 102–1083.2. Effect of copper on HNF4α expression
The previous results indicate that HNF4α contributes to the
regulation of selected target genes and that copper also modulates the
expression of these genes. To directly assess the effect of copper on
HNF4α expression, HepG2 cells were exposed to various concentra-
tions of copper (0, 100, 200, 400, and 600 μM) for 4 h. Exposure to
copper concentrations above 200 μM produced signiﬁcant decreases
in HNF4α mRNA levels (Fig. 2A). Exposure to 200, 400, and 600 μM
copper reduced HNF4α mRNA levels to 67%, 46%, and 33% of that
observed in nonexposed cells, respectively.
Transfection of HepG2 cells with HNF4α siRNA reduced the
steady-state HNF4α mRNA level to 19% of that observed in cellsFig. 2. Effect of copper on HNF4α mRNA and protein expression. (A) Steady-state
HNF4αmRNA levels in HepG2 cells exposed to 0, 100, 200, 400, and 600 μM copper for
4 h. *Signiﬁcant difference from control (pb0.005; n=4). (B) Steady-state levels of
HNF4α mRNA, measured using qRT-PCR (gray bars; n=10), and protein levels,
determined by Western immunoblotting of whole cell lysates (open bars; n=3). Data
are expressed as mean percent ± standard error (SE) relative to cells not exposed to
copper. *Signiﬁcant difference relative to cells transfected with control siRNA
(pb0.0001). #Signiﬁcant difference relative to cells transfected with control siRNA
and exposed to copper (pb0.0001). (C) Representative Western immunoblot of whole
cell lysates probed with antibodies to HNF4α and β-actin.transfected with non-homologous control siRNA (Fig. 2B). The level of
HNF4α mRNA in HNF4α siRNA transfected cells exposed to 400 μM
copper for 4 h was only 9% of that observed in control cells. In these
cells, the level of HNF4α mRNA expression was signiﬁcantly lower
than that observed in cells treated with copper or transfected with
HNF4α siRNA alone.
Comparable results were obtainedwhenHNF4α protein levels were
measured by Western immunoblotting. Exposure of HepG2 cells to
400 μMcopper signiﬁcantly reducedHNF4αprotein levels to 40%of that
observed in non-copper-treated cells (Figs. 2B and C). Reduction of
HNF4α expression using siRNA (14% of control levels) signiﬁcantly
lowered HNF4α protein levels to 5.9% of that observed in cells
transfected with control siRNA. The addition of 400 μM copper to
HNF4α siRNA-treated cells resulted in a further signiﬁcant reduction of
HNF4α protein levels to 3.3% of that observed in control cells (Figs. 2B
and C). These results indicate that treatment with copper reduces both
HNF4α protein and mRNA levels.
3.3. Effect of copper on HNF4α DNA binding activity
DNA binding assays were performed to determine if copper
exposure would lead to a decrease in HNF4α binding to its consensus
binding motif. HepG2 cells were exposed to copper (0, 200, 400, and
600 μM) for 2 h. This exposure time was chosen based on preliminary
binding assay data (Supplemental Fig. 1). The level of HNF4α binding
decreased in a dose-dependent manner: HNF4α binding in cells
exposed to 400 and 600 μM copper was 53% and 18% of that observed
in control cells, respectively (Fig. 3). HNF4α binding also decreased in
a time-dependent manner at 400 and 600 μM copper (Supplemental
Fig. 1). The speciﬁcity of HNF4α binding in this assay was conﬁrmed
by competition with oligonucleotides that contained wild-type and
nonfunctional HNF4α consensus sequences (results not shown).
3.4. Effect of copper on p53-mediated HNF4α expression
The transcription of human HNF4α is reported to be negatively
regulated by p53 [21]. To conﬁrm this observation in HepG2 cells the
steady-state level of HNF4αmRNA was determined following knock-
down of p53 expression using siRNA. An 84%±3.5% reduction in p53
expression resulted in a signiﬁcant 197%±29.5% increase in the level
of HNF4α mRNA. This result conﬁrmed that p53 regulated HNF4α
expression in HepG2 cells.
In the HepG2 copper transcriptome, metal exposure did not
signiﬁcantly affect p53 mRNA levels at any concentration or exposure
time examined [10]. These results are consistent with previous
observations that demonstrated p53 activation results from protein
stabilization and post-translational modiﬁcations rather than changes
in gene expression (reviewed in Pluquet and Hainaut [28]). To
investigate the role of p53 in copper-induced down-regulation of
HNF4α expression, the effect of copper on p53 protein expressionwasFig. 3. Effect of copper on HNF4α binding activity. Nuclear extracts were prepared from
HepG2 cells exposed to 0, 200, 400, and 600 μM copper for 2 h. Data are expressed as
means±SE relative to cells not exposed to copper (n=3). *Signiﬁcantly different from
nontreated cells, pb0.001.
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fromHepG2 cells treatedwith copper (0, 100, 200, 400, or 600 μM) for
4 h. The level of p53 increased in a dose-dependent manner in both
whole-cell lysates and nuclear extracts (Figs. 4A and B, respectively).
In nuclear extracts, HNF4α protein decreased 1.28-, 2.27-, and 2.44-
fold when exposed to 200, 400, and 600 μM copper, respectively
(Fig. 4C; Supplemental Table 1). The levels of p53 increased 1.67-fold
relative to controls following exposure to 400 μM copper and 2.56-
fold after exposure to 600 μM copper (Fig. 4C; Supplemental Table 1).
These results support a model where p53 mediates copper-induced
down-regulation of HNF4α.
The steady-state level of p53 is regulated in part by ATF3 [29]. To
further deﬁne a mechanism by which copper can affect the levels of
HNF4α, the effect of copper exposure on ATF3 protein expression was
determined. ATF3 protein levels in both whole cell lysates and in
nuclear extracts increased in a dose-dependent manner when HepG2
cells were exposed to copper for 4 h (Figs. 4A and B). In nuclear
extracts, ATF3 protein levels signiﬁcantly increased 15.5- and 20.4-
fold following exposure to 400 μM and 600 μM copper, respectively
(Fig. 4C; Supplemental Table 1). This is in agreement with previous
expression proﬁling results showing that copper signiﬁcantly up-
regulated ATF3 mRNA levels [10].
To further investigate the role of ATF3 in mediating p53 protein
activation/stabilization in response to copper, the effect of exposure
time on ATF3, p53 and HNF4α protein levels was determined. ATF3
and p53 protein levels remained constant until 4 h when signiﬁcant
increases in protein levels were observed. A signiﬁcant decrease in
HNF4α protein level was only observed following 8 h of exposure
(Fig. 5). These results support a model in which copper can affect
HNF4α-mediated transcription through ATF3 and then p53.Fig. 5. Effect of copper on HNF4α, ATF3, and p53—time response. (A) Whole cell lysates
were prepared fromHepG2 cells exposed to 400 μM copper for 1, 2, 4 and 8 h. ATF3 (■),
p53 (♦), and HNF4α (▲) protein levels were quantiﬁed and normalized against those of
tubulin. Data are expressed as fold change of treated sample over that of nontreated
sample of each exposure time. *pb0.05 and #pb0.001, signiﬁcantly different from 1 h
treated sample. (B) Representative Western immunoblot of whole cell lysates probed
with antibodies to ATF3, p53, HNF4α, and tubulin.
Fig. 4. Effect of copper on HNF4α, ATF3, and p53—concentration response.
Representative Western immunoblot of (A) whole cell lysates or (B) nuclear extracts
prepared from HepG2 cells exposed to 0, 100, 200, 400, and 600 μM, or 0 and 400 μM
copper for 4 h, respectively. (C) Target nuclear protein levels were quantiﬁed by
densitometry using Image J software, and normalized against those of histone 3. Data
are expressed as fold change of treated samples over that of nontreated sample.
*Signiﬁcantly different from nontreated sample (pb0.01).3.5. Effect of ATF3 on HNF4α and p53
To further explore the role of ATF3 in p53 activity, the effect of
ATF3 RNAi on copper-mediated activation of p53 and HNF4α
expression was examined. Transfection of HepG2 cells with ATF3
siRNA resulted in a signiﬁcant (50%±6.1%) decrease in ATF3 and a
nonsigniﬁcant (40%) increase in p53 protein levels relative to
controls. Treatment with ATF3 siRNA produced a nonsigniﬁcant 20%
increase in HNF4α protein levels. Similarly, ATF3 siRNA treatment did
not signiﬁcantly affect HNF4α mRNA levels (results not shown).
4. Discussion
Several studies have examined changes in global gene expression
associated with exposure to elevated levels of copper. These studies
have led to a better understanding of the molecular mechanisms
underlying the physiological and toxicological processes affected by
copper [23,30,31]. A common observation from toxicogenomic
analyses is the ability of chemicals and toxicants to affect the
expression of hundreds to thousands of genes. In the transcriptome
of HepG2 cells, copper affected the steady-state level of 2,257 mRNAs:
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sion [10]. The expression of many of these genes could be directly
linked to metal exposure (e.g., metallothioneins) or metal-induced
stress (heat shock proteins, glutamate-cysteine ligase). For a majority
of the genes, however, direct links between copper exposure and
affected genes were not apparent. This may be due to the ability of
metals to affect the activity of central transcription factors, which
regulate the expression of hundreds of genes. Bioinformatic analysis
of copper-responsive genes identiﬁed HNF4α as a potential central
transcription factor. The HNF4α module for copper-responsive genes
contained 242 up-regulated and 498 down-regulated genes (Fig. 1).
This represented ~30 % of the total genes in the HNF4αmodule [10]. A
map of the transcriptional regulatory circuitry of human hepatocytes
shows that HNF4α is one of the six master regulators [15].
RNAi and Western immunoblot analyses demonstrated that
copper could suppress HNF4α protein expression, which ultimately
affected the transcription of several target genes. The ability of copper
to suppress HNF4α expression was partially controlled by p53. Over-
expression of p53 suppresses HNF4α protein levels [21]. In the
present study, immunoblot analysis showed that copper exposure
caused a signiﬁcant increase in p53 protein levels. In MCF-7 cells, p53
protein levels also increased following copper exposure [32].
Copper-inducible expression of p53 may be regulated by ATF3.
ATF3 is a member of the ATF/CREB family of transcription factors and
is a stress-inducible gene [33]. ATF3 positively regulates p53 levels by
increasing protein stability [29]. ATF3 transcription is induced by a
variety of agents including growth-stimulating factors, cytokines,
genotoxic agents, signaling molecules, bacterial products, and viral
proteins (reviewed in Hai and Hartman [34] and Hai et al. [35]).
Copper signiﬁcantly increased ATF3 mRNA levels 1.2- to 19.3-fold
relative to non-exposed HepG2 cells, which conﬁrmed ATF3 as a
copper-responsive gene [10]. Western analysis of copper-treated
HepG2 cells showed ATF3 protein levels increased as a function of
metal concentration and exposure time. p53 protein levels showed a
similar pattern of increase, although ATF3 protein levels appeared to
be ~10-fold higher than those of p53 at identical copper concentra-
tions. Time-course analysis showed ATF3 and p53 protein levels
remained constant until 4 h after copper exposure; after which levels
signiﬁcantly increased. HNF4α protein levels increased only after ATF
and p53 protein accumulated. These results suggest a kinetic
relationship between ATF3 and p53 expression and down-regulation
of HNF4α. These observations and previous reports support a model
in which copper exposure causes an increase in ATF3 protein levels
that results in the stabilization of p53. The elevation in p53 causes a
decrease in HNF4α levels, which ultimately affects transcription of its
downstream target genes (Fig. 6).
Reduction of ATF3 expression did not signiﬁcantly affect HNF4α or
p53 levels (data not shown). This may be due to the low efﬁciency
(b50%) in the suppression of ATF3 expression. An alternativeFig. 6. Model describing the mechanism by which copper can affect HNF4α-mediated
transcription. In this model, exposure to copper causes an increase in ATF3 activity/
levels or induces DNA damage that produces an increase in p53. Elevated p53 down-
regulates HNF4α levels which ultimately affects the transcription of its target genes.explanation was that copper affected p53 levels via an ATF3-
independent mechanism (Fig. 6). Exposure of cells to elevated
concentrations of copper leads to oxidative DNA damage that could
activate p53 [6,36,37]. Alternatively, copper could directly promote
post-translational modiﬁcations of p53. p53 is stabilized by different
stresses through post-translational modiﬁcations, including phos-
phorylation, acetylation, methylation, ubiquitination, and sumoyla-
tion (reviewed in Lavin and Gueven [38]). Toxic concentrations of
copper produce intracellular stress that could induce some of these
post-translational modiﬁcations. Transcriptome analysis of copper-
treated HepG2 cells showed that p300 was signiﬁcantly up-regulated
(1.4–1.7 fold) by 400 and 600 μM copper [10]. Considering that p300
can acetylate p53 [38], toxic concentration of copper could induce p53
acetylation through p300. Copper may also directly act on p53 to
affect its activity. In vitro studies, using in vitro-translated p53 and
cell-free systems, demonstrated that copper could induce conforma-
tional changes in p53 and inhibit its DNA-binding activity at
physiological concentrations (b30 μM) [39,40].
Under normal conditions, humans maintain homeostatic levels of
copper. Individuals with Wilson disease, however, accumulate toxic
levels of hepatic copper. Wilson disease is caused by mutations in the
gene coding the ATPase copper pump, ATP7B, which transports
copper out of the cytoplasm [41]. As a result, copper accumulates to
toxic levels in hepatocytes leading to steatosis, inﬂammation,
cirrhosis, and ultimately liver failure (reviewed in Brewer [42] and
Langner and Denk [43]). Recent molecular mechanistic studies on the
pathology of Wilson disease indicate a link between copper overload
and a disruption in lipid metabolism [44,45]. Copper selectively
down-regulates genes associated with lipid metabolism and transport
in the Wilson disease model Atp7b−/− mice. Affected genes include
low-density lipoprotein receptor (LDLR) and HMG-CoA reductase,
both of which are regulated by SREBP-2 (sterol regulatory-element
binding protein 2). Huster and Lutsenko [44] suggested that cross-talk
between copper and lipid metabolism may involve several mechan-
isms including modulation of SREBP-2 activity. This suggests that
elevated copper may inhibit SREBP-2 activity. SREBP-2 activity is
affected by HNF4α. Overexpression of HNF4α causes an increase in
SREBP-2 activity and both proteins were found to directly interact
with each other [46,47]. Thus, the ability of copper to negatively affect
lipid metabolism may be due to copper-induced inhibition of HNF4α.
Further support of this mechanism for copper-induced disruption
of lipid metabolism comes from studies of Hnf4α−/−mice [18]. These
mice present liver steatosis and reduced serum cholesterol levels,
which are phenotypes similar to those observed in individuals with
Wilson disease and Atp7b−/−mice [42,43,45,48]. Hnf4α−/−mice also
show reduced expression of genes involved in several pathways of
lipid metabolism and transport [18]. qRT-PCR and RNAi results clearly
demonstrated that decreased HNF4α expression and copper down-
regulated the expression of LIPA, APOC1, and APOM, which are
involved in maintaining lipid homeostasis (Table 2). In addition,
transcriptome analysis of HepG2 cells exposed to toxic levels of
copper showed down-regulation of genes associatedwithmetabolism
and transport of biomolecules including lipids [10]. Taken together,
these results indicate that copper down-regulates genes associated
with lipid metabolism and transport through the down-regulation of
HNF4α. Furthermore, HNF4α may be an important factor linking
copper overload to the disruption in lipid metabolism.
Several lines of evidence support the hypothesis that HNF4α is a
master regulator of copper-responsive transcription. HNF4α down-
regulation by copper leads to altered expression of hundreds of target
genes. This in turn may deﬁne the molecular mechanism underlying
the physiological and toxicological consequences of copper toxicity. In
addition, these results suggest that the physiological changes in lipid
metabolism associated with copper overload/toxicity may be con-
trolled by HNF4α. These observations provide novel insights into the
molecular mechanism of human copper toxicity.
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